FDA approves Jalyn™, a fixed-dose combination of dutasteride and tamsulosin, for symptomatic BPH in men with an enlarged prostate
BPH is one of the most common prostate disorders, affecting nearly half of all men 50 years of age or older in the U.S.
Read the full article16y agoen
You might also wanna read
OpenAI No. 2 Executive Fidji Simo Steps Down from Full-Time Role to Focus on Health Recovery
Variety·4h ago
Why ambulance rides in the US are so expensive: The broken economics of emergency medical transport
davidoks.blog·6h agoModerna's mResvia gets shot in the arm from EU contract
pharmaphorum·6h ago
Australia news live: Hanson defends UK ‘fact-finding’ trip; Qantas tops airline punctuality table
The Guardian·6h ago
STAT+: FDA finalists under review
STAT·13h ago
STAT+: Prime wins Beam arbitration, clearing path to clinic
STAT·14h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.